EUCTR2011-002526-43-IT进行中（未招募）不适用
Single and Repeat Dose Study of the Safety and Efficacy of AGN-150998 in Patients with Exudative Age-related Macular Degeneration - REACH Study
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 204
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. active exudative age-related macular degeneration 2. best-corrected visual acuity between 20/40 and 20/320
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 184
排除标准
- •1. Females who are pregnant, nursing, or of child-bearing potential and not on adequate birth control 2. near-sightedness of 8 diopters or more 3. glaucoma 4. cataract surgery or Lasik within the last 3 months 5. any active ocular infection or inflammation
研究者
相似试验
进行中（未招募）
不适用
Single and Repeat Dose Study of the Safety and Efficacy of AGN-150998 in Patients with wet Age-related Macular DegeneratioExudative Age-related Macular DegenerationMedDRA version: 14.1Level: LLTClassification code 10025411Term: Macular degeneration senileSystem Organ Class: 10015919 - Eye disordersEUCTR2011-002526-43-DEAllergan Limited204
进行中（未招募）
不适用
Single and Repeat Dose Study of the Safety and Efficacy of AGN-150998 in Patients with wet Age-related Macular DegeneratioEUCTR2011-002526-43-ATAllergan Limited204
已完成
不适用
A Single Dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic Rhinitis Patients Challenged Intranasally with Allergen Extractallergic rhinitiscat allergy1000170810046304NL-OMON40738Regeneron Pharmaceuticals, Inc.20
已完成
1 期
A single centre, double blind, randomised, parallel group, single and multiple dose, safety and tolerability, pharmacokinetic study of R131-2 vaginal soft gel capsule in healthy women volunteersCervical neoplasiaCondyloma acuminatumInfection - Sexually transmitted infectionsACTRN12621001487808Zenith Technology Corporation Limited12
进行中（未招募）
1 期
An international trial of deferiprone in patients with Parkinson’s diseaseParkinson’s diseaseMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004344-19-GBApoPharma140